Publicacions en col·laboració amb investigadors/es de Martin Luther University Halle-Wittenberg (23)

2024

  1. Epigenetic-based differentiation therapy for Acute Myeloid Leukemia

    Nature Communications, Vol. 15, Núm. 1

  2. Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1016-1027

2023

  1. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  2. Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial

    HEPATOLOGY COMMUNICATIONS, Vol. 7, Núm. 6

2022

  1. Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

    Otology and Neurotology, Vol. 43, Núm. 5, pp. 513-529

2021

  1. An update on endotoxin neutralization strategies in Gram-negative bacterial infections

    Expert Review of Anti-Infective Therapy, Vol. 19, Núm. 4, pp. 495-517

  2. Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Núm. 27

2019

  1. Synthetic anti-lipopolysaccharide peptides (SALPs) as effective inhibitors of pathogen-associated molecular patterns (PAMPs)

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 111-129

2018

  1. Inhibition of lipopolysaccharide- and lipoprotein-induced inflammation by antitoxin peptide Pep19-2.5

    Frontiers in Immunology

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2015

  1. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671

  2. Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014

    Journal of Translational Medicine, Vol. 13, Núm. 1

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  2. Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013

    Journal of Translational Medicine, Vol. 12, Núm. 1

2013

  1. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Nature Genetics, Vol. 45, Núm. 12, pp. 1452-1458

2012

  1. Bacterial cell wall compounds as Promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines

    Current Drug Targets, Vol. 13, Núm. 9, pp. 1121-1130

  2. Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspects

    Current Drug Targets, Vol. 13, Núm. 9, pp. 1131-1137

2011

  1. Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides

    Biophysical Journal, Vol. 100, Núm. 11, pp. 2652-2661

2010

  1. Effective antimicrobial and anti-endotoxin activity of cationic peptides based on lactoferricin: A biophysical and microbiological study

    Anti-Infective Agents in Medicinal Chemistry, Vol. 9, Núm. 1, pp. 9-22

  2. Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells

    Innate Immunity, Vol. 16, Núm. 1, pp. 39-47